journal club stuff Flashcards
overall glycine decarboxylase (GLDC)
effects in mice
causes neural tube defects
cuases features of non-ketotic hyperglycinemia
which mechanism is linked to human neural tube defects (NTDs)
aberrant folate metabolism
effect of Glycine decarboxylase (GLDC) on folate metabolism
provides the carbon units
what do GLDC mutations cause
non-ketonic hyperglycinemia
linked to NTDs
GLDC
glycine decarboxylase
NTD
neural tube defect
mice with reduced GLDC activity
develop (non-ketotic hyperglycinemia) NKH
NTDs
altered folate profiles
administration of formate to mice with reduced GLDC activity
reverses effects of NKH and NTD by providing an alternative source of carbon units and normalising folate profile
mitochondrial folate metabolsim is important in
neural tube development
what are drugs that target GABA signalling used for
anti-anxiety anti-convulsants analgesic anaesthetics muscle relaxants
GABAa receptors
pentometric
ligand-gated ion channels
diverse subunit composition mixture
different subunit compositions of GABAs receptor s
confer different receptor properties
give different physiological effects
different physiological effects of GABAa receptors
drugs have different binding affinities for GABAa receptors
GABAa binding sites
2 orthosteric binding sites
1 allosteric binding/modulatory site
also a possible alternative site
muscimol
selective agonist for GABAa receptor
binds to the orthosteric site
fluni-traz-epam
benzodiazepine
binds to modulatory/allosteric site
allosteric modulator
substance which directly influences the effects of a receptor agonist or inverse agonist at its receptor target
where do allosteric modulators bind
a site distinct from the orthosteric site where a receptor agonist would normally bind
effect of allosteric modulator on structure of receptor
usually induce a conformational change within the protein strucutre
EC10
concentration of an agonist that produces 10% of the maximal possible effect of that agonist
docking binding energy
a measure of how well the ligand binds the receptor binding site
more negative docking binding energy
the better the ligand ‘fits’ the receptor binding site
DCUK-OEt
subunit-selective positive allosteric modulator at the GABAa receptor
where does DCUK-OEt bind to GABAa receptors
appears to act at a site distinct from the benzodiaepine site
example of a monosynaptic pathway
Schaffer Collateral Commissural pathway